INSIGHTS ON PHARMACEUTICAL LOGISTICS

• Validating The Stability And Durability Of Labels After Thawing From Cryogenic Temperatures

  One important element of working in cryogenic temperatures involves ensuring labels remain intact and securely adhered to packaging after application as product moves from ambient temperatures to cryogenic temperatures to thawing at the point of use. The following study serves as a model for the need to validate label stability and adherence and is an example of the many different types of validation studies we regularly conduct to mitigate risk for customers during all phases of an advanced therapy clinical trial.

• Managing Refrigerated vs. Frozen Drug Product: What’s The Big Deal?

  The most common storage is ultra-low temperature storage, but the fastest-growing is cryogenic, in vapor phase liquid nitrogen. This transition is huge. Chain of temperature and custody data is imperative.  

• Global Air Cargo Trends Re-Shaping Pharmaceutical Transport

  As we welcome the new decade and the exciting advances it is expected to unleash, many of the forces that shaped the past decade for transporting pharmaceuticals will continue. Price pressures, alternatives to air freight and increasing automation are just a few. However, there are emerging trends that make 2020 unique. As we look forward, these are the air cargo trends expected to shape the transport of pharmaceuticals in 2020 and beyond.

• Minimizing Errors And Saving Time In Drug Receipt Processes

  The speed-accuracy trade-off is a well-known phenomenon in psychology for processes requiring human input: the faster you go, the more likely it is that errors will be introduced into the system. 

• Controlling Complexity (Not Cost) Of Advanced Therapy Supply Chains

  Due to the short shelf life and clinical criticality of advanced therapies, their supply chains are often highly complex.  Once efficacy and safety is demonstrated, the focus of advanced therapy developers moves to controlling cost.  However, the biggest cost within the supply chain is caused by its complexity.  In this article, we will share why the advanced therapy supply chain is so complex and how this complexity correlates to cost.

• Securing Bioprocess Film Supply

  Learn how a partnership built on technical expertise and trust is helping to secure the supply of a single-use film built for bioprocessing.

• Meet Aggressive Timelines By Simplifying Your Drug Delivery Supply Chain

  To meet an aggressive timeline with a lack of resources, Kaleido Biosciences had to consider an alternative yet efficient route for drug substance, drug product, and clinical trial packaging needs.

• The Power of Digital Transformation

  The pharmaceutical contract services supply chain is not traditionally a sector where technology is a first mover. Approximately 18 months ago, however, PCI Pharma Services determined that there were sufficient proof points in the industry indicating that it should incorporate digital transformation as core to its business strategy. While the company continues on this journey, PCI Pharma Services is already realizing both measurable and intangible benefits.

• Direct-To-Representative Sample Distribution Services

  One particularly effective approach to promote prescription drug products is to have pharma sales reps ‘hand carry’ samples to the health care practitioners within their territories.